World's Best Scientists 2026 revealed!

D-Index & Metrics

Genetics

D-Index
73
Citations
19139
World Ranking
2045
National Ranking
934

Medicine

D-Index
74
Citations
19296
World Ranking
19422
National Ranking
9674

Overview

Harry A. Drabkin is affiliated with the Medical University of South Carolina in the United States. Their research primarily focuses on the fields of Biochemistry, Genetics and Molecular Biology, and Medicine, with specific contributions in Molecular Biology, Oncology, and Cancer Research.

The main topics explored in their work include:

  • Angiogenesis and VEGF in Cancer
  • Cancer Cells and Metastasis
  • Lymphatic System and Diseases
  • Cancer, Hypoxia, and Metabolism
  • Glycosylation and Glycoproteins Research

Drabkin has contributed to recent scientific literature with notable papers such as:

  • Neuropilin-2b facilitates resistance to tyrosine kinase inhibitors in non-small cell lung cancer, published in 2020 in the Journal of Thoracic and Cardiovascular Surgery
  • Abstract 2994: Inhibition of the NRP2b:GSK3β binding interaction with peptides and macrocycles exerts anticancer effects in lung cancer, published in 2020 in Cancer Research

Their frequent co-authors include:

  • Anastasios Dimou
  • Cécile Nasarre
  • Yuri K. Peterson
  • Patrick Nasarre
  • Kent Armeson

Publications have appeared in venues such as the Journal of Thoracic and Cardiovascular Surgery and Cancer Research, reflecting the intersection of Drabkin's molecular biology expertise with cancer-related investigations.

Best Publications

  • Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial

    Robert J. Motzer;Brian I. Rini;David F. McDermott;Bruce G. Redman

  • Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion

    Gilles David;Nacer Abbas;Giovanni Stevanin;Alexandra Dürr

  • Von Hippel–Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma

    B. R. Seizinger;G. A. Rouleau;L. J. Ozelius;A. H. Lane

  • Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt.

    P Erickson;J Gao;KS Chang;T Look

  • Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines.

    Samir E. Witta;Robert M. Gemmill;Fred R. Hirsch;Christopher D. Coldren

  • High-Throughput Tissue Microarray Analysis Used to Evaluate Biology and Prognostic Significance of the E-Cadherin Pathway in Non–Small-Cell Lung Cancer

    Roy M. Bremnes;R. Veve;E. Gabrielson;F. R. Hirsch

  • Randomized Phase II Study of Erlotinib Combined With Bevacizumab Compared With Bevacizumab Alone in Metastatic Renal Cell Cancer

    Ronald M. Bukowski;Fairooz F. Kabbinavar;Robert A. Figlin;Keith Flaherty

  • Unified nomenclature for the semaphorins/collapsins [1]

    J. A. Bamberg;S. Baumgartner;H. Betz;J. Bolz

  • A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma.

    Jonathan E. Rosenberg;Jonathan E. Rosenberg;Richard M. Bambury;Eliezer M. Van Allen;Eliezer M. Van Allen;Harry A. Drabkin

  • Cyclooxygenase-2-dependent regulation of E-cadherin: prostaglandin E(2) induces transcriptional repressors ZEB1 and snail in non-small cell lung cancer

    Mariam Dohadwala;Seok-Chul Yang;Jie Luo;Sherven Sharma

  • Inhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21.3 candidate tumor suppressor gene SEMA3B

    Yoshio Tomizawa;Yoshitaka Sekido;Yoshitaka Sekido;Masashi Kondo;Boning Gao

  • Safety and efficacy results of the advanced renal cell carcinoma sorafenib expanded access program in North America

    Walter M. Stadler;Robert A. Figlin;David F. McDermott;Janice P. Dutcher

  • Altered hox and wnt7a expression in human lung cancer

    Harry A. Drabkin;Robert M. Gemmill

  • Angiogenic Squamous Dysplasia in Bronchi of Individuals at High Risk for Lung Cancer

    Robert L. Keith;York E. Miller;Robert M. Gemmill;Harry A. Drabkin

  • Detection of DNA Rearrangements in the AML1 and ETO Loci and of an AML1/ETO Fusion mRNA in Patients With t(8;21) Acute Myeloid Leukemia

    Giuseppina Nucifora;Debra J. Birn;Paul Erickson;Jizong Gao

  • Hematopoietic stem cell expansion and distinct myeloid developmental abnormalities in a murine model of the AML1-ETO translocation.

    Cristina G. de Guzman;Alan J. Warren;Zheng Zhang;Larry Gartland

  • Distinct 3p21.3 deletions in lung cancer and identification of a new human semaphorin.

    Roche J;Boldog F;Robinson M;Robinson L

  • An AML1/ETO fusion transcript is consistently detected by RNA-based polymerase chain reaction in acute myelogenous leukemia containing the (8;21)(q22;q22) translocation

    J. R. Downing;D. R. Head;A. M. Curcio-Brint;M. G. Hulshof

  • Quantitative HOX expression in chromosomally defined subsets of acute myelogenous leukemia.

    H A Drabkin;C Parsy;K Ferguson;F Guilhot

  • The 3;21 translocation in myelodysplasia results in a fusion transcript between the AML1 gene and the gene for EAP, a highly conserved protein associated with the Epstein-Barr virus small RNA EBER 1

    Giuseppina Nucifora;Catherine R. Begy;Paul Erickson;Harry A. Drabkin

Frequent Co-Authors

Robert M. Gemmill
Robert M. Gemmill Medical University of South Carolina
David F. McDermott
David F. McDermott Beth Israel Deaconess Medical Center
Wilbur A. Franklin
Wilbur A. Franklin University of Colorado Denver
Anna E. Barón
Anna E. Barón University of Colorado Anschutz Medical Campus
Ronald M. Bukowski
Ronald M. Bukowski Cleveland Clinic
Robert J. Motzer
Robert J. Motzer Memorial Sloan Kettering Cancer Center
Ulka N. Vaishampayan
Ulka N. Vaishampayan University of Michigan–Ann Arbor
Jan Trka
Jan Trka Charles University
Elisabeth Brambilla
Elisabeth Brambilla Grenoble Alpes University
Charles H.C.M. Buys
Charles H.C.M. Buys University of Groningen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Genetics opens doors to diverse and rewarding fields. Many students interested in genetics also explore health and life sciences, especially advanced nursing and clinical roles. With the growing demand for skilled healthcare professionals, online programs are increasingly popular due to their flexibility and affordability.

For those aiming to advance quickly in nursing, there are options such as the rn to bsn online cheap and fast programs. These pathways allow registered nurses to obtain their Bachelor of Science in Nursing efficiently and affordably. If you aspire to further your clinical practice, consider the online dnp fnp programs, which lead to advanced practitioner roles such as Family Nurse Practitioners.

Searching for the cheapest np school or the most affordable online nursing programs can significantly reduce your financial burden. Affordable online options make it easier to gain the qualifications needed for in-demand healthcare careers without leaving your job or relocating. These pathways provide a bridge between genetic science studies and practical, impactful medical careers.

Best Scientists Citing Harry A. Drabkin

Trending Scientists

Recently Published Articles